Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROSTAGLANDIN-G/H SYNTHASE-1' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Colville-Nash, PR; Gilroy, DW
      Potential adverse effects of cyclooxygenase-2 inhibition: Evidence from animal models of inflammation

      BIODRUGS
    2. Young, IR
      The comparative physiology of parturition in mammals

      ENDOCRINOLOGY OF PARTURITION: BASIC SCIENCE AND CLINICAL APPLICATION
    3. Kothekar, V; Sahi, S; Srinivasan, M; Mohan, A; Mishra, J
      Recognition of cyclooxygenase-2 (COX-2) active site by NSAIDs: A computer modelling study

      INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS
    4. Brown, WA; Skinner, SA; Vogiagis, D; O'Brien, PE
      Inhibition of beta-catenin translocation in rodent colorectal tumors - A novel explanation for the protective effect of nonsteroidal antiinflammatorydrugs in colorectal cancer

      DIGESTIVE DISEASES AND SCIENCES
    5. Sharma, RA; Gescher, A; Plastaras, JP; Leuratti, C; Singh, R; Gallacher-Horley, B; Offord, E; Marnett, LJ; Steward, WP; Plummer, SM
      Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells

      CARCINOGENESIS
    6. Wiese, FW; Thompson, PA; Kadlubar, FF
      Carcinogen substrate specificity of human COX-1 and COX-2

      CARCINOGENESIS
    7. van Rees, BP; Ristimaki, A
      Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    8. Riendeau, D; Percival, MD; Brideau, C; Charleson, S; Dube, D; Ethier, D; Falgueyret, JP; Friesen, RW; Gordon, R; Greig, G; Guay, J; Mancini, J; Ouellet, M; Wong, E; Xu, L; Boyce, S; Visco, D; Girard, Y; Prasit, P; Zamboni, R; Rodger, IW; Gresser, M; Ford-Hutchinson, AW; Young, RN; Chan, CC
      Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Wong, E; Huang, JQ; Tagari, P; Riendeau, D
      Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits

      ATHEROSCLEROSIS
    10. Brown, WA; Skinner, SA; Malcontenti-Wilson, C; Vogiagis, D; O'Brien, PE
      Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation

      GUT
    11. Oshima, M; Murai, N; Kargman, S; Arguello, M; Luk, P; Kwong, E; Taketo, MM; Evans, JF
      Chemoprevention of intestinal polyposis in the Apc(Delta 716) mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor

      CANCER RESEARCH
    12. Denkert, C; Kobel, M; Berger, S; Siegert, A; Leclere, A; Trefzer, U; Hauptmann, S
      Expression of cyclooxygenase 2 in human malignant melanoma

      CANCER RESEARCH
    13. Ohno, R; Yoshinaga, K; Fujita, T; Hasegawa, K; Iseki, H; Tsunozaki, H; Ichikawa, W; Nihei, Z; Sugihara, K
      Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

      CANCER
    14. Gilroy, DW; Colville-Nash, PR
      New insights into the role of COX 2 in inflammation

      JOURNAL OF MOLECULAR MEDICINE-JMM
    15. Moore, BC; Simmons, DL
      COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs

      CURRENT MEDICINAL CHEMISTRY
    16. Brown, WA; Skinner, SA; Malcontenti-Wilson, C; Misajon, A; DeJong, T; Vogiagis, D; O'Brien, PE
      Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    17. Kitayama, W; Denda, A; Yoshida, J; Sasaki, Y; Takahama, M; Murakawa, K; Tsujiuchi, T; Tsutsumi, M; Konishi, Y
      Increased expression of cyclooxygenase-2 protein in rat lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine

      CANCER LETTERS
    18. Dubois, RN
      Review article: cyclooxygenase - a target for colon cancer prevention

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    19. Kalgutkar, AS; Crews, BC; Rowlinson, SW; Marnett, AB; Kozak, KR; Remmel, RP; Marnett, LJ
      Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    20. Singla, AK; Chawla, M; Singh, A
      Nimesulide: Some pharmaceutical and pharmacological aspects - An update

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    21. Tsubouchi, Y; Sano, H; Yamada, R; Hashiramoto, A; Kohno, M; Kusaka, Y; Kondo, M
      Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Castelao, JE; Yuan, JM; Gago-Dominguez, M; Yu, MC; Ross, RK
      Non-steroidal anti-inflammatory drugs and bladder cancer prevention

      BRITISH JOURNAL OF CANCER
    23. Cannon, GW; Caldwell, JR; Holt, P; McLean, B; Seidenberg, B; Bolognese, J; Ehrich, E; Mukhopadhyay, S; Daniels, B
      Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium - Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

      ARTHRITIS AND RHEUMATISM
    24. Lipsky, PE; Brooks, P; Crofford, LJ; DuBois, R; Graham, D; Simon, LS; van de Putte, LBA; Abramson, SB
      Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease

      ARCHIVES OF INTERNAL MEDICINE
    25. Day, R; Morrison, B; Luza, A; Castaneda, O; Strusberg, A; Nahir, M; Helgetveit, KB; Kress, B; Daniels, B; Bolognese, J; Krupa, D; Seidenberg, B; Ehrich, E
      A randomized trial of the efficacy and tolerability of the COX-2 inhibitorrofecoxib vs ibuprofen in patients with osteoarthritis

      ARCHIVES OF INTERNAL MEDICINE
    26. Chapple, KS; Cartwright, EJ; Hawcroft, G; Tisbury, A; Bonifer, C; Scott, N; Windsor, ACJ; Guillou, PJ; Markham, AF; Coletta, PL; Hull, MA
      Localization of cyclooxygenase-2 in human sporadic colorectal adenomas

      AMERICAN JOURNAL OF PATHOLOGY
    27. Shah, AA; Murray, FE; Fitzgerald, DJ
      The in vivo assessment of nimesulide cyclooxygenase-2 selectivity

      RHEUMATOLOGY
    28. Prasit, P; Wang, Z; Brideau, C; Chan, CC; Charleson, S; Cromlish, W; Ethier, D; Evans, JF; Ford-Hutchinson, AW; Gauthier, JY; Gordon, R; Guay, J; Gresser, M; Kargman, S; Kennedy, B; Leblanc, Y; Leger, S; Mancini, J; O'Neill, GP; Ouellet, M; Percival, MD; Perrier, H; Riendeau, D; Rodger, I; Tagari, P; Therien, M; Vickers, P; Wong, E; Xu, LJ; Young, RN; Zamboni, R; Boyce, S; Rupniak, N; Forrest, N; Visco, D; Patrick, D
      The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    29. Pouplana, R; Perez, C; Sanchez, J; Lozano, JJ; Puig-Parellada, P
      The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    30. Powell, DW; Mifflin, RC; Valentich, JD; Crowe, SE; Saada, JI; West, AB
      Myofibroblasts. II. Intestinal subepithelial myofibroblasts

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    31. Gierse, JK; Koboldt, CM; Walker, MC; Seibert, K; Isakson, PC
      Kinetic basis for selective inhibition of cyclo-oxygenases

      BIOCHEMICAL JOURNAL
    32. Kitayama, W; Denda, A; Okajima, E; Tsujiuchi, T; Konishi, Y
      Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

      CARCINOGENESIS
    33. Dammann, HG
      Preferential COX-2 inhibition: Its clinical relevance for gastrointestinalNSAID toxicity

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    34. DeWitt, DL
      Cox-2-selective inhibitors: The new super aspirins

      MOLECULAR PHARMACOLOGY
    35. Pairet, M; van Ryn, J
      Measurement of differential inhibition of COX-1 and COX-2 and the pharmacology of selective inhibitors

      DRUGS OF TODAY
    36. Chan, CC; Boyce, S; Brideau, C; Charleson, S; Cromlish, W; Ethier, D; Evans, J; Ford-Hutchinson, AW; Forrest, MJ; Gauthier, JY; Gordon, R; Gresser, M; Guay, J; Kargman, S; Kennedy, B; Leblanc, Y; Leger, S; Mancini, J; O'Neill, GP; Ouellet, M; Patrick, D; Percival, MD; Perrier, H; Prasit, P; Rodger, I; Tagari, P; Therien, M; Vickers, P; Visco, D; Wang, Z; Webb, J; Wong, E; Xu, LJ; Young, RN; Zamboni, R; Riendeau, D
      Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    37. Ehrich, EW; Dallob, A; De Lepeleire, I; Van Hecken, A; Riendeau, D; Yuan, WY; Porras, A; Wittreich, J; Seibold, JR; De Schepper, P; Mehlisch, DR; Gertz, BJ
      Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    38. Nantel, F; Denis, D; Gordon, R; Northey, A; Cirino, M; Metters, KM; Chan, CC
      Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation

      BRITISH JOURNAL OF PHARMACOLOGY
    39. Hull, MA; Booth, JK; Tisbury, A; Scott, N; Bonifer, C; Markham, AF; Coletta, PL
      Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice

      BRITISH JOURNAL OF CANCER
    40. Marnett, LJ; Kalgutkar, AS
      Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

      TRENDS IN PHARMACOLOGICAL SCIENCES
    41. VANE J
      DIFFERENTIAL INHIBITION OF CYCLOOXYGENASE ISOFORMS - AN EXPLANATION OF THE ACTION OF NSAIDS

      Journal of clinical rheumatology
    42. PAIRET M
      INHIBITION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 - ANALYSIS OF IN-VITRO TEST SYSTEMS AND THEIR CLINICAL RELEVANCE

      Journal of clinical rheumatology
    43. PAIRET M; VANRYN J
      EXPERIMENTAL-MODELS USED TO INVESTIGATE THE DIFFERENTIAL INHIBITION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      Inflammation research
    44. TAKETO MM
      COX-2 AND COLON-CANCER

      Inflammation research
    45. VANE JR; BAKHLE YS; BOTTING RM
      CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2

      Annual review of pharmacology and toxicology
    46. VANE JR; BOTTING RM
      MECHANISM OF ACTION OF ANTIINFLAMMATORY DRUGS

      International journal on tissue reactions
    47. Uefuji, K; Ichikura, T; Mochizuki, H; Shinomiya, N
      Expression of cyclooxygenase-2 protein in gastric adenocarcinoma

      JOURNAL OF SURGICAL ONCOLOGY
    48. SINGER II; KAWKA DW; SCHLOEMANN S; TESSNER T; RIEHL T; STENSON WF
      CYCLOOXYGENASE-2 IS INDUCED IN COLONIC EPITHELIAL-CELLS IN INFLAMMATORY BOWEL-DISEASE

      Gastroenterology
    49. OKAJIMA E; DENDA A; OZONO S; TAKAHAMA M; AKAI H; SASAKI Y; KITAYAMA W; WAKABAYASHI K; KONISHI Y
      CHEMOPREVENTIVE EFFECTS OF NIMESULIDE, A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR, ON THE DEVELOPMENT OF RAT URINARY-BLADDER CARCINOMAS INITIATED BY N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE

      Cancer research
    50. BELLOSILLO B; PIQUE M; BARRAGAN M; CASTANO E; VILLAMOR N; COLOMER D; MONTSERRAT E; PONS G; GIL J
      ASPIRIN AND SALICYLATE INDUCE APOPTOSIS AND ACTIVATION OF CASPASES INB-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS

      Blood
    51. SIMON LS; LANZA FL; LIPSKY PE; HUBBARD RC; TALWALKER S; SCHWARTZ BD; ISAKSON PC; GEIS GS
      PRELIMINARY-STUDY OF THE SAFETY AND EFFICACY OF SC-58635, A NOVEL CYCLOOXYGENASE-2 INHIBITOR - EFFICACY AND SAFETY IN 2 PLACEBO-CONTROLLED TRIALS IN OSTEOARTHRITIS AND RHEUMATOID-ARTHRITIS, AND STUDIES OF GASTROINTESTINAL AND PLATELET EFFECTS

      Arthritis and rheumatism
    52. PERCIVAL MD; BASTIEN L; GRIFFIN PR; KARGMAN S; OUELLET M; ONEILL GP
      INVESTIGATION OF HUMAN CYCLOOXYGENASE-2 GLYCOSYLATION HETEROGENEITY AND PROTEIN EXPRESSION IN INSECT AND MAMMALIAN-CELL EXPRESSION SYSTEMS

      Protein expression and purification
    53. SOYDAN AS; GAFFEN JD; WEECH PK; TREMBLAY NM; KARGMAN S; ONEILL G; BENNETT A; TAVARES IA
      CYTOSOLIC PHOSPHOLIPASE A(2), CYCLO-OXYGENASES AND ARACHIDONATE IN HUMAN STOMACH TUMORS

      European journal of cancer
    54. DAVIES NM; SHARKEY KA; ASFAHA S; MACNAUGHTON WK; WALLACE JL
      ASPIRIN CAUSES RAPID UP-REGULATION OF CYCLO-OXYGENASE-2 EXPRESSION INTHE STOMACH OF RATS

      Alimentary pharmacology & therapeutics
    55. TSUJII M; KAWANO S; DUBOIS RN
      CYCLOOXYGENASE-2 EXPRESSION IN HUMAN COLON-CANCER CELLS INCREASES METASTATIC POTENTIAL

      Proceedings of the National Academy of Sciences of the United Statesof America
    56. SHENG HM; SHAO JY; KIRKLAND SC; ISAKSON P; COFFEY RJ; MORROW J; BEAUCHAMP RD; DUBOIS RN
      INHIBITION OF HUMAN COLON-CANCER CELL-GROWTH BY SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2

      The Journal of clinical investigation
    57. WILLIAMS CS; SMALLEY W; DUBOIS RN
      ASPIRIN USE AND POTENTIAL MECHANISMS FOR COLORECTAL-CANCER PREVENTION

      The Journal of clinical investigation
    58. RIENDEAU D; CHARLESON S; CROMLISH W; MANCINI JA; WONG E; GUAY J
      COMPARISON OF THE CYCLOOXYGENASE-1 INHIBITORY PROPERTIES OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) AND SELECTIVE COX-2 INHIBITORS, USING SENSITIVE MICROSOMAL AND PLATELET ASSAYS

      Canadian journal of physiology and pharmacology
    59. CROMLISH WA; KENNEDY BP
      SELECTIVE-INHIBITION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 USING INTACT INSECT-CELL ASSAYS

      Biochemical pharmacology
    60. FREED KA; AITKEN MA; BRENNECKE SP; RICE GE
      PROSTAGLANDIN G H SYNTHASE-1 MESSENGER-RNA RELATIVE ABUNDANCE IN HUMAN AMNION, CHORIODECIDUA AND PLACENTA BEFORE, DURING AND AFTER SPONTANEOUS ONSET LABOR AT TERM/

      Gynecologic and obstetric investigation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 23:12:33